Abstract:Background and purpose:Pancreatic carcinoma is a kind of malignant disease with the rising tendency of incidence and poor prognosis.Little progress has been made on the treatment of advanced pancreatic carcinoma during the past 2 decades.The combined mordality for the unresectable pancreatic carcinoma is controversial.We retrospectively reviewed the clinical data and the results of transarterial intervention alone or transarterial intervention combined with radiotherapy,analyzed the prognostic factors for patients with unresectable pancreatic carcinoma.Methods:We retrospective analyzed 105 patients with locally advanced and metastatic pancreatic carcinoma.Univariate and multivariate statistical methods were used to determine significant prognostic factors and therapy program for overall survival(OS).Results:For all patients,the median survival time(MST) was 9.0 months,1-year and 2-year OS were 31.2% and 12.2% respectively.For the locally advanced vs phase Ⅳ patients,the MST,1-year,2-year OS were 9.1 vs 7.6 months,33.2% vs 29.3% and 14.7% vs 9.1% respectively.On univariate analysis,the number of interventional therapy,whether combined with radiotherapy or not,the choice of gemcitabine programs and primary tumor site were important factors for OS.For all 105 patients,the MST of patients who received multiple transarterial therapy was 4.9 months longer than those who had single therapy(12.5 vs 7.6 monthes,P=0.010).1-year and 2-year OS were 51.5% vs 22.2% and 20.7% vs 8.1%.The MST of patients who received combined therapy was 4.3 months longer compared with who had only interventional therapy(11.9 vs 7.6 monthes,P=0.003),1-year,2-year OS were 48.5% vs 21.8% and 27.7% vs 2.7%.The MST of patients who received gemcitabine programs was 2.2 months longer compared with who had other programs(9.8 vs 7.6 monthes,P=0.018),1-year,2-year OS were 37.5% vs 18.8% and 20.3% vs 3.1%.The MST of patients with pancreatic head cancer was 3.0 months longer compared with the patients whose cancer located in pancreatic body or tail(10.5 vs 7.5 monthes,P=0.031),1-year,2-year OS were 40.2% vs 22.0% and 6.3% vs 8.8%.On multivariate analysis,Interventional therapy combined radiotherapy was independent prognostic factor for OS,it could decrease death risk for all patients 46%(95%CI: 0.272-0.891,P=0.047).Conclusion:In the current study,transarterial intervention combined with radiotherapy can improve overall survival among patients with unresectable pancreatic cancer.

Transcatheter Arterial Infusion for Pancreatic Cancer: a 10-Year National Cancer Center Experience in 115 Patients and Literature Review

Analysis of the Efficacy of Transcatheter Arterial Infusion Chemotherapy in the Treatment of Pancreatic Carcinoma

Therapeutic Effect of Transcatheter Arterial Infusion Chemotherapy in the Treatment of Advanced Pancreatic Cancer

Transarterial Infusion with Gemcitabine and Oxaliplatin for the Treatment of Unresectable Pancreatic Cancer

Transcatheter Arterial Infusion Combined with Radioactive Particles in the Treatment of Advanced Body/Tail Pancreatic Cancer

Transcatheter arterial infusion combined with radioactive particles in the treatment of advanced body/tail pancreatic cancer: a retrospective cohort study

[Efficacy of Selective Continuous Transarterial Infusion Chemotherapy on Advanced Pancreatic Cancer].

Efficacy of continuous arterial perfusion chemotherapy combined with transarterial chemoembolization regional arterial thermal perfusion in the treatment of pancreatic cancer with liver metastases

Diffusion‐weighted MRI Monitoring of Pancreatic Cancer Response to Radiofrequency Heat‐enhanced Intratumor Chemotherapy

Treatment of Advanced Pancreatic Cancer by Transarterial Infusion of Gemcitabine

Efficacy and Safety of Nab-Paclitaxel Plus Gemcitabine in the Treatment of Advanced Pancreatic Cancer by Transcatheter Arterial Chemotherapy

Intratumoral Radiofrequency Hyperthermia-Enhanced Direct Chemotherapy of Pancreatic Cancer

A retrospective analysis of patients with unresectable pancreatic cancer treated with combined transarterial intervention and three dimensional conformal radiotherapy

Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.

Transcatheter arterial embolization for cancer-related non-variceal upper gastrointestinal bleeding: A multicenter retrospective study of 107 patients

[The Study of Clinical Value of Transarterial Chemical Perfusion As Second-Line Therapy for Late Stage Pancreatic Cancer].

Transcatheter Arterial Chemoembolization For Patients With Hepatic Metastasis Of Nonfunctional Pancreatic Neuroendocrine Neoplasms

The Clinical Efficacy of Computed Tomography-Guided 125I Particle Implantation Combined with Arterial Infusion Chemotherapy in the Treatment of Pancreatic Cancer.

A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization

Trans-port-catheter System Arterial Infusion of Gemcitabine and 5-Fluorouracil for Treatment of Advanced Pancreatic Cancer

CT-guided 125I Seed Implantation Combined with Pancreatic Arterial Infusion in Treatment of Advanced Pancreatic Cancer